Pharmaco - Press Releases

Date	Title	Company
26-Jul-2021	SYNLAB integrates Gruppo Tronchet into its international diagnostics network, consolidating its number one position in Italy and further strengthening its service offering	SYNLAB AG
26-Jul-2021	Cosmo Pharmaceuticals Announces Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi® in US and Canada	Cosmo Pharmaceuticals N.V.
26-Jul-2021	Relief Therapeutics Announces CHF 15 Million Private Placement	RELIEF THERAPEUTICS Holdings AG
26-Jul-2021	Cassiopea SpA and Sun Pharma Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada	Cassiopea S.p.A.
25-Jul-2021	IGEA ALL EQUITY OFFER TO BLUE SKY NATURAL RESOURCES LTD NOW UNCONDITIONAL AS TO ACCEPTANCES	IGEA Pharma N.V.
23-Jul-2021	Fieldfisher publishes white paper - The future of medicine: Cell and gene therapy	Fieldfisher
23-Jul-2021	Cell and Gene Therapy Catapult celebrates one-year anniversary since receiving funding to setup its world-class manufacturing innovation facility in Braintree, Essex	Cell and Gene Therapy Catapult (CGT Catapult)
23-Jul-2021	Foresight Diagnostics’ PhasED-Seq Circulating Tumor DNA Platform Demonstrates Highly Sensitive Minimal Residual Disease (MRD) Detection in B-Cell Lymphomas	Foresight Diagnostics
23-Jul-2021	ProductLife Group accelerates expansion with acquisition of global regulatory outsourcing company ELC Group	ProductLife Group (PLG)
23-Jul-2021	ADVANZ PHARMA announces launch of MYTOLAC® in Germany, the first generic lanreotide for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs)	ADVANZ PHARMA
23-Jul-2021	Global Anti-Infective Vaccines Market Research Report Up to 2031	Visiongain Ltd.
23-Jul-2021	Abivax announces the pricing of its oversubscribed capital increase of EUR 60m and convertible bonds of EUR 25m, totaling eur 85m new financing	ABIVAX
23-Jul-2021	Lonza Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3% CORE EBITDA Margin	Lonza Group AG
23-Jul-2021	Relief Reports that its U.S. Collaboration Partner has Announced Successful Commercial Formulation for Aviptadil	RELIEF THERAPEUTICS Holdings AG
22-Jul-2021	Abivax capital increase and convertible bonds issue to qualified investors for an aggregate amount of approximately EUR 80m	ABIVAX
22-Jul-2021	Adoption of AI solutions and AI in Genomics Market Growth	Markets and Markets
22-Jul-2021	The LEO Foundation announces closing of Nordic Capital’s investment in LEO Pharma	LEO Foundation
22-Jul-2021	Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders	Takeda
22-Jul-2021	Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children with ADHD	PureTech
22-Jul-2021	Optimal orientation aid for patients	Faller Packaging